The Biden administration expects to take delivery of 4 million courses of Covid-19 treatments by the end of January, including 265,000 courses of Pfizer Inc.’s newly authorized pill, according to officials familiar with the matter -- sharply ramping up therapies for the disease as the omicron variant spreads.
Pfizer’s pill was authorized Wednesday by the Food and Drug Administration, and authorization for Merck & Co.’s pill was also expected this week.
